Mortality associated with HIV-1, HIV-2, and HTLV-I single and dual infections in a middle-aged and older population in Guinea-Bissau. 2007

Birgitta Holmgren, and Zacarias da Silva, and Pernille Vastrup, and Olav Larsen, and Sören Andersson, and Henrik Ravn, and Peter Aaby
Bandim Health Project, Bissau, INDEPTH Network, Guinea-Bissau. Birgitta_G.Holmgren@med.lu.se

BACKGROUND In Guinea-Bissau HIV-1, HIV-2, and HTLV-I are prevalent in the general population. The natural history of HIV/HTLV-I single and dual infections has not been fully elucidated in this population. Previous studies have shown that combinations of these infections are more common in older women than in men. The present study compares mortality associated with HIV-1, HIV-2, and HTLV-I single and dual infections in individuals over 35 years of age within an urban community-based cohort in Guinea-Bissau. RESULTS A total of 2,839 and 1,075 individuals were included in the HIV and HTLV-I mortality analyses respectively. Compared with HIV-negative individuals, adjusted mortality rate ratios (MRRs) were 4.9 (95% confidence interval (CI): 2.3, 10.4) for HIV-1, 1.8 (95%CI: 1.5, 2.3) for HIV-2, and 5.9 (2.4, 14.3) for HIV-1/HIV-2 dual infections. MRR for HTLV-I-positive compared with HTLV-I-negative individuals was 1.7 (1.1, 2.7). Excluding all HIV-positive individuals from the analysis, the HTLV-I MRR was 2.3 (1.3, 3.8). The MRR of HTLV-I/HIV-2 dually infected individuals was 1.7 (0.7, 4.3), compared with HIV/HTLV-I-negative individuals. No statistically significant differences were found in retrovirus-associated mortality between men and women. CONCLUSIONS HIV-1-associated excess mortality was low compared with community studies from other parts of Africa, presumably because this population was older and the introduction of HIV-1 into the community recent. HIV-2 and HTLV-I-associated mortality was 2-fold higher than the mortality in uninfected individuals. We found no significant differences between the mortality risk for HIV-2 and HTLV-I single infection, respectively, and HIV-2/HTLV-I dual infection. The higher prevalence of retroviral dual infections in older women is not explained by differential retrovirus-associated mortality for men and women.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006169 Guinea-Bissau A republic in western Africa, south of SENEGAL and west of GUINEA. Its capital is Bissau. Guinea, Portuguese,Portuguese Guinea,Guinea-Bissau, Republic of,Republic of Guinea-Bissau
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D014505 Urban Population The inhabitants of a city or town, including metropolitan areas and suburban areas. Urban Residence,Urban Spatial Distribution,Distribution, Urban Spatial,Distributions, Urban Spatial,Population, Urban,Populations, Urban,Residence, Urban,Urban Populations,Urban Residences,Urban Spatial Distributions
D015331 Cohort Studies Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics. Birth Cohort Studies,Birth Cohort Study,Closed Cohort Studies,Cohort Analysis,Concurrent Studies,Historical Cohort Studies,Incidence Studies,Analysis, Cohort,Cohort Studies, Closed,Cohort Studies, Historical,Studies, Closed Cohort,Studies, Concurrent,Studies, Historical Cohort,Analyses, Cohort,Closed Cohort Study,Cohort Analyses,Cohort Studies, Birth,Cohort Study,Cohort Study, Birth,Cohort Study, Closed,Cohort Study, Historical,Concurrent Study,Historical Cohort Study,Incidence Study,Studies, Birth Cohort,Studies, Cohort,Studies, Incidence,Study, Birth Cohort,Study, Closed Cohort,Study, Cohort,Study, Concurrent,Study, Historical Cohort,Study, Incidence
D015368 Human T-lymphotropic virus 1 A strain of PRIMATE T-LYMPHOTROPIC VIRUS 1 isolated from mature T4 cells in patients with T-lymphoproliferation malignancies. It causes adult T-cell leukemia (LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED), T-cell lymphoma (LYMPHOMA, T-CELL), and is involved in mycosis fungoides, SEZARY SYNDROME and tropical spastic paraparesis (PARAPARESIS, TROPICAL SPASTIC). ATLV,Adult T-Cell Leukemia-Lymphoma Virus I,HTLV-1,HTLV-I,Human T-Cell Leukemia Virus I,Leukemia Virus I, Human T-Cell,T-Cell Leukemia Virus I, Human,Adult T Cell Leukemia Lymphoma Virus I,Human T Cell Leukemia Virus I,Leukemia Lymphoma Virus I, Adult T Cell,Leukemia Virus I, Human T Cell,T Cell Leukemia Virus I, Human,Human T lymphotropic virus 1

Related Publications

Birgitta Holmgren, and Zacarias da Silva, and Pernille Vastrup, and Olav Larsen, and Sören Andersson, and Henrik Ravn, and Peter Aaby
May 1992, AIDS (London, England),
Birgitta Holmgren, and Zacarias da Silva, and Pernille Vastrup, and Olav Larsen, and Sören Andersson, and Henrik Ravn, and Peter Aaby
August 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association,
Birgitta Holmgren, and Zacarias da Silva, and Pernille Vastrup, and Olav Larsen, and Sören Andersson, and Henrik Ravn, and Peter Aaby
August 2016, Infectious diseases (London, England),
Birgitta Holmgren, and Zacarias da Silva, and Pernille Vastrup, and Olav Larsen, and Sören Andersson, and Henrik Ravn, and Peter Aaby
March 2015, Virology journal,
Birgitta Holmgren, and Zacarias da Silva, and Pernille Vastrup, and Olav Larsen, and Sören Andersson, and Henrik Ravn, and Peter Aaby
September 2010, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases,
Birgitta Holmgren, and Zacarias da Silva, and Pernille Vastrup, and Olav Larsen, and Sören Andersson, and Henrik Ravn, and Peter Aaby
January 1989, Journal of acquired immune deficiency syndromes,
Birgitta Holmgren, and Zacarias da Silva, and Pernille Vastrup, and Olav Larsen, and Sören Andersson, and Henrik Ravn, and Peter Aaby
December 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association,
Birgitta Holmgren, and Zacarias da Silva, and Pernille Vastrup, and Olav Larsen, and Sören Andersson, and Henrik Ravn, and Peter Aaby
July 2002, Journal of acquired immune deficiency syndromes (1999),
Birgitta Holmgren, and Zacarias da Silva, and Pernille Vastrup, and Olav Larsen, and Sören Andersson, and Henrik Ravn, and Peter Aaby
March 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association,
Birgitta Holmgren, and Zacarias da Silva, and Pernille Vastrup, and Olav Larsen, and Sören Andersson, and Henrik Ravn, and Peter Aaby
September 1999, Virology,
Copied contents to your clipboard!